Research programme: osteoarthritis therapy - Canadian Arthritis Network/GeneNews
Alternative Names: Osteoarthritis therapy research programme - Canadian Arthritis Network/GeneNewsLatest Information Update: 01 Jun 2007
At a glance
- Originator Canadian Arthritis Network; GeneNews Limited
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis
Most Recent Events
- 01 Jun 2007 Discontinued - Preclinical for Osteoarthritis in Canada (unspecified route)
- 03 Nov 2006 ChondroGene is now called GeneNews
- 04 Dec 2003 Preclinical trials in Osteoarthritis in Canada (unspecified route)